歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Apoptosis > PF-3084014

瀏覽歷史

S81281

PF-3084014

源葉(MedMol) ≥98%
  • 英文名:
  • PF-3084014
  • 別名:
  • Nirogacestat;PF-03084014 (PF-3084014), PF03084014, PF 03084014, PF-03084014, PF-3084014, PF03084014, PF-03084014, 化合物PF03084014, PF-3084014, PF 03084014
  • CAS號:
  • 1290543-63-3
  • 分子式:
  • C27H41F2N5O
  • 分子量:
  • 489.64
品牌貨號產品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數量計量單位 加入購物車...
源葉(MedMol) S81281-5mg ≥98% ¥730.00元 4 - - - EA 加入購物車
源葉(MedMol) S81281-10mg ≥98% ¥943.00元 6 - - - EA 加入購物車
源葉(MedMol) S81281-25mg ≥98% ¥1961.00元 3 - - - EA 加入購物車
源葉(MedMol) S81281-50mg ≥98% ¥4531.00元 2 - - - EA 加入購物車
源葉(MedMol) S81281-100mg ≥98% ¥6487.00元 2 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權與保護申明》,到貨后將短信提示。
提交

產品介紹

參考文獻

質檢證書(COA)

摩爾濃度計算器

相關產品

  • 提示:詳情請下載說明書。
  • 產品描述: PF-03084014 (PF-3084014) is a specific γ-secretase inhibitor (IC50: 6.2 nM, in a cell-free assay).
  • 靶點: Apoptosis;Gamma-secretase;Apoptosis;?Gamma-secretase
  • 體外研究:
    PF-03084014 inhibits Notch receptor cleavage in HPB-ALL cells that harbor mutations in both the heterodimerization and PEST domains in Notch1 (IC50: 13.3 nM). PF-03084014 downregulates Notch target genes Hes-1 (IC50<1 nM) and cMyc expression (IC50:10 nM) in HPB-ALL cells, respectively. PF-03084014 inhibits cell growth of a subset of human T-ALL cell lines (HPB-ALL, DND-41, TALL-1, and Sup-T1) through induction of cell cycle arrest and apoptosis (IC50s: 30-100 nM). PF-03084014 reduces proliferation of HUVECs (IC50: 0.5 μM) and decreases the lumen formation (IC50: 50 nM). PF-03084014 (1 μM) has no antiproliferative effect in MX1 cells; however, it inhibits migration by 95%.
  • 體內研究:
    PF-03084014 (200 mg/kg, p.o.) causes maximal NICD inhibition for ~80% in xenograft HPB-ALL tumors. PF-03084014 shows robust antitumor activity in this mode with a maximal tumor growth inhibition of 92% at the dose of 150 mg/kg, accompanied by a significant reduction of NICD/Notch1, tumor mitotic index (Ki67), and apoptosis (activated caspase-3) staining. PF-03084014 (120 mg/kg) induces apoptosis, antiproliferation, reduces tumor cell self-renewal ability, impairs tumor vasculature, and decreases metastasis activity in breast cancer HCC1599 tumor-bearing mice. In various types of the breast xenograft models, PF-03084014 has significant antitumor activity (TGI>50%).
  • 細胞實驗: Cell lines: Human T-ALL cell lines HPB-ALL. Concentrations: ~1 μM. Method: Cells are seeded in 96-well plates at 10,000 cells/well in growth media supplemented with 10% fetal bovine serum.Serial dilutions of PF-03084014 are done in DMSO,appropriate controls or designated concentrations of PF-03084014 are added to each well,and cells are incubated at 37℃ for 7 days (final DMSO content 0.1%).Resazurin at a final concentration of 0.1 mg/mL is added to the cells and plates are incubated for 2 to 4 hours.Fluorescent signals are read as emission at 590 nm after excitation at 560 nm.
  • 動物實驗: Animal Models: Human T-cell acute lymphoblastic leukemia xenografts HPB-ALL. Formulation: 0.5% methylcellulose. Dosages: 150 mg/kg,b.i.d. Administration: p.o.
  • 參考文獻:
    1. Wei P, et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther. 2010 Jun;9(6):1618-28. 2. Zhang CC, et al. Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models. Clin Cancer Res, 2012, 18(18), 52008-52019. 3. Li YM, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA, 2000, 97(11), 6138-6143.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.042 ml 10.212 ml 20.423 ml
    5 mM 0.408 ml 2.042 ml 4.085 ml
    10 mM 0.204 ml 1.021 ml 2.042 ml
    50 mM 0.041 ml 0.204 ml 0.408 ml
  • 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
  • 提示:詳情請下載說明書。
  • 產品描述: PF-03084014 (PF-3084014) is a specific γ-secretase inhibitor (IC50: 6.2 nM, in a cell-free assay).
  • 靶點: Apoptosis;Gamma-secretase;Apoptosis;?Gamma-secretase
  • 體外研究:
    PF-03084014 inhibits Notch receptor cleavage in HPB-ALL cells that harbor mutations in both the heterodimerization and PEST domains in Notch1 (IC50: 13.3 nM). PF-03084014 downregulates Notch target genes Hes-1 (IC50<1 nM) and cMyc expression (IC50:10 nM) in HPB-ALL cells, respectively. PF-03084014 inhibits cell growth of a subset of human T-ALL cell lines (HPB-ALL, DND-41, TALL-1, and Sup-T1) through induction of cell cycle arrest and apoptosis (IC50s: 30-100 nM). PF-03084014 reduces proliferation of HUVECs (IC50: 0.5 μM) and decreases the lumen formation (IC50: 50 nM). PF-03084014 (1 μM) has no antiproliferative effect in MX1 cells; however, it inhibits migration by 95%.
  • 體內研究:
    PF-03084014 (200 mg/kg, p.o.) causes maximal NICD inhibition for ~80% in xenograft HPB-ALL tumors. PF-03084014 shows robust antitumor activity in this mode with a maximal tumor growth inhibition of 92% at the dose of 150 mg/kg, accompanied by a significant reduction of NICD/Notch1, tumor mitotic index (Ki67), and apoptosis (activated caspase-3) staining. PF-03084014 (120 mg/kg) induces apoptosis, antiproliferation, reduces tumor cell self-renewal ability, impairs tumor vasculature, and decreases metastasis activity in breast cancer HCC1599 tumor-bearing mice. In various types of the breast xenograft models, PF-03084014 has significant antitumor activity (TGI>50%).
  • 細胞實驗: Cell lines: Human T-ALL cell lines HPB-ALL. Concentrations: ~1 μM. Method: Cells are seeded in 96-well plates at 10,000 cells/well in growth media supplemented with 10% fetal bovine serum.Serial dilutions of PF-03084014 are done in DMSO,appropriate controls or designated concentrations of PF-03084014 are added to each well,and cells are incubated at 37℃ for 7 days (final DMSO content 0.1%).Resazurin at a final concentration of 0.1 mg/mL is added to the cells and plates are incubated for 2 to 4 hours.Fluorescent signals are read as emission at 590 nm after excitation at 560 nm.
  • 動物實驗: Animal Models: Human T-cell acute lymphoblastic leukemia xenografts HPB-ALL. Formulation: 0.5% methylcellulose. Dosages: 150 mg/kg,b.i.d. Administration: p.o.
  • 參考文獻:
    1. Wei P, et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther. 2010 Jun;9(6):1618-28. 2. Zhang CC, et al. Biomarker and pharmacologic evaluation of the γ-secretase inhibitor PF-03084014 in breast cancer models. Clin Cancer Res, 2012, 18(18), 52008-52019. 3. Li YM, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA, 2000, 97(11), 6138-6143.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.042 ml 10.212 ml 20.423 ml
    5 mM 0.408 ml 2.042 ml 4.085 ml
    10 mM 0.204 ml 1.021 ml 2.042 ml
    50 mM 0.041 ml 0.204 ml 0.408 ml
  • 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產品批號:

本計算器可幫助您計算出特定溶液中溶質的質量、溶液濃度和體積之間的關系,公式為:


質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產品僅用作科學研究,銷售產品行為均適用于我司網上所列通用銷售條款。
点击收缩